Search by Drug Name or NDC
NDC 00135-0537-03 PANADOL 160 mg/5mL Details
PANADOL 160 mg/5mL
PANADOL is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN.
Product Information
| NDC | 00135-0537 |
|---|---|
| Product ID | 0135-0537_7bad4144-ffbc-4d33-9a1d-95b4b39cd637 |
| Associated GPIs | 64200010001840 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | PANADOL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | acetaminophen |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 160 |
| Active Ingredient Units | mg/5mL |
| Substance Name | ACETAMINOPHEN |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00135-0537-03 (00135053703)
| NDC Package Code | 0135-0537-03 |
|---|---|
| Billing NDC | 00135053703 |
| Package | 1 BOTTLE in 1 CARTON (0135-0537-03) / 118 mL in 1 BOTTLE |
| Marketing Start Date | 2012-10-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |